Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis
Clinical trial NCT03421002 · COMPLETED
Trial details
- NCT number
- NCT03421002
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-30
- Primary completion
- 2018-04-10
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.